Peter A. Riedell
Impact in
- Oncology top 2%
- CAR-T cell therapy research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 92
- CAR-T cell therapy research 84
-
- Lymphoma Diagnosis and Treatment 31
- Co-authors
- Sonali M. Smith (12 shared papers)Olalekan O. Oluwole (26 shared papers)Michael R. Bishop (32 shared papers)Joseph P. McGuirk (24 shared papers)Veronika Bachanová (20 shared papers)Kenneth R. Carson (10 shared papers)Loretta J. Nastoupil (19 shared papers)Miguel‐Angel Perales (21 shared papers)
- Journals
- Blood (44 papers)Blood Advances (11 papers)Transplantation and Cellular Therapy (10 papers)Journal of Clinical Oncology (8 papers)Hematological Oncology (3 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Peter A. Riedell
105 papers receiving 1.5k citations
Peter A. Riedell's Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 1.0k
- Pathology and Forensic Medicine 467
- Genetics 213
- Geriatrics and Gerontology 39
- Hematology 126
Countries citing papers authored by Peter A. Riedell
This map shows the geographic impact of Peter A. Riedell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Riedell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Riedell more than expected).
Fields of papers citing papers by Peter A. Riedell
This network shows the impact of papers produced by Peter A. Riedell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Riedell. The network helps show where Peter A. Riedell may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter A. Riedell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial Hit paper breakdown → | 2022 | 198 |
| 2 | 2018 | 141 | |
| 3 | 2021 | 88 | |
| 4 | Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial Hit paper breakdown → | 2025 | 66 |
| 5 | 2019 | 60 | |
| 6 | 2020 | 57 | |
| 7 | 2019 | 51 | |
| 8 | 2022 | 51 | |
| 9 | 2015 | 50 | |
| 10 | 2016 | 38 | |
| 11 | 2016 | 38 | |
| 12 | 2020 | 34 | |
| 13 | 2022 | 29 | |
| 14 | 2016 | 28 | |
| 15 | 2020 | 27 | |
| 16 | 2020 | 25 | |
| 17 | 2019 | 25 | |
| 18 | 2020 | 25 | |
| 19 | 2022 | 23 | |
| 20 | 2018 | 21 |
About Peter A. Riedell
Peter A. Riedell is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Genetics and Molecular Biology, having authored 118 papers that have together received 1.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (84 papers), Lymphoma Diagnosis and Treatment (31 papers), Biosimilars and Bioanalytical Methods (23 papers), Chronic Lymphocytic Leukemia Research (20 papers), Integrated Circuits and Semiconductor Failure Analysis (14 papers), Viral Infectious Diseases and Gene Expression in Insects (12 papers), Acute Myeloid Leukemia Research (7 papers) and Biomedical Ethics and Regulation (7 papers). The work is most often cited by research in Oncology (1.0k citations), Pathology and Forensic Medicine (467 citations), Genetics (213 citations), Geriatrics and Gerontology (39 citations) and Hematology (126 citations). Peter A. Riedell has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Sonali M. Smith, Olalekan O. Oluwole, Michael R. Bishop, Joseph P. McGuirk, Veronika Bachanová, Kenneth R. Carson, Loretta J. Nastoupil, Miguel‐Angel Perales, David L. Porter and Richard T. Maziarz. Their work appears in journals such as Blood, Blood Advances, Transplantation and Cellular Therapy, Journal of Clinical Oncology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.